Letícia P Pinto
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Letícia P Pinto has a total of 5 co-authors. Here are the top co-authors by number of shared publications:
- Cristiane Valle Tovo
Universidade Federal de Ciências da Saúde de Porto Alegre (UFCSPA), Internal Medicine Department and Graduate Program in Hepatology, Porto Alegre, RS, Brazil
1 shared publication - Débora Silva Costa
Centro Universitário Metodista IPA, Brasil
1 shared publication - Fernanda Braga Seganfredo
Instituto Português de Oncologia de Lisboa Francisco Gentil ‐ IPOLFG (Hematology Department) Lisboa Portugal
1 shared publication - Marina Petrasi Guahnon
Hospital Moinhos de Vento – Porto Alegre – Rio Grande do Sul – Brasil
1 shared publication - Sabrina Alves Fernandes
Santa Casa de Porto Alegre Hospital Complex, Porto Alegre 90020-090, Rio Grande do Sul, Brazil.
1 shared publication
Latest Publications
- Open Access
- 1 June 2021
- Published by FapUNIFESP (SciELO) in Arquivos de Gastroenterologia
- Vol. 58 (2) , 234-239
VITAMIN B12 AND HOMOCYSTEINE LEVELS IN PATIENTS WITH NAFLD: A SYSTEMATIC REVIEW AND METANALYSIS
BACKGROUND: The vitamin B12 absorption can be affected in patients with nonalcoholic fatty liver disease (NAFLD), and low serum vitamin B12 levels has been related to the high homocysteine (HCY) levels and to the degree of NAFLD. OBJECTIVE: To carry out a systematic review and metanalysis of serum vitamin B12 and HCY levels in patients with NAFLD. METHODS: Original studies including serum vitamin B12 and HCY levels in humans with NAFLD were included. The searches were performed in four databases. RESULTS: 159 studies were identified, and after excluding the duplicates and non-eligible titles, eight original articles were included. Six out of eight showed higher B12 levels in NAFLD patients (404.9±136.2 pg/mL in relation to controls 353.91±117.3 pg/mL). Seven of the eight studies also showed higher HCY levels in NAFLD patients (14.2±3.44 umol/L in relation to controls 11.05±3.6 umol/L). The results for serum vitamin B12 and HCY levels were submitted to metanalysis, showing no difference in the vitamin B12 levels between patients with NAFLD and controls. However, the levels of Hcy were higher in NAFLD patients than in controls. CONCLUSION: There was no relashionship between the vitamin B12 levels and NAFLD. The levels of HCY were significantly higher in patients with NAFLD, suggesting this could be a potential marker for liver damage.
- 1 June 2021
- Published by FapUNIFESP (SciELO) in Arquivos de Gastroenterologia
- Vol. 58 (2) , 234-239
Open AccessVITAMIN B12 AND HOMOCYSTEINE LEVELS IN PATIENTS WITH NAFLD: A SYSTEMATIC REVIEW AND METANALYSIS
BACKGROUND: The vitamin B12 absorption can be affected in patients with nonalcoholic fatty liver disease (NAFLD), and low serum vitamin B12 levels has been related to the high homocysteine (HCY) levels and to the degree of NAFLD. OBJECTIVE: To carry out a systematic review and metanalysis of serum vitamin B12 and HCY levels in patients with NAFLD. METHODS: Original studies including serum vitamin B12 and HCY levels in humans with NAFLD were included. The searches were performed in four databases. RESULTS: 159 studies were identified, and after excluding the duplicates and non-eligible titles, eight original articles were included. Six out of eight showed higher B12 levels in NAFLD patients (404.9±136.2 pg/mL in relation to controls 353.91±117.3 pg/mL). Seven of the eight studies also showed higher HCY levels in NAFLD patients (14.2±3.44 umol/L in relation to controls 11.05±3.6 umol/L). The results for serum vitamin B12 and HCY levels were submitted to metanalysis, showing no difference in the vitamin B12 levels between patients with NAFLD and controls. However, the levels of Hcy were higher in NAFLD patients than in controls. CONCLUSION: There was no relashionship between the vitamin B12 levels and NAFLD. The levels of HCY were significantly higher in patients with NAFLD, suggesting this could be a potential marker for liver damage.